What are the HIV postexposure prophylaxis (PEP) regimens during pregnancy?

Updated: Jul 08, 2021
  • Author: Derek T Larson, DO; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

PEP is especially important in pregnant women and should not be avoided because of known or possible pregnancy.

Note that tenofovir alafenamide (TAF), a newer formulation of tenofovir, has not been specifically studied for HIV PEP and is not currently recommended for this indication. A TAF-containing co-formulation with emtricitabine (Descovy) is FDA-approved for the treatment of HIV infection in combination with other active agents, but its ultimate role in HIV PEP remains undefined at the time of this writing.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!